TRAW - Traws Pharma, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.94 -0.14 (-4.76%)	---	---	0.0 (0.0%)	0.0 (0.0%)	-0.16 (-5.3%)	-0.09 (-3.11%)	-0.09 (-3.11%)

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.11
Diluted EPS:: -0.11
Basic P/E:: -25.4545
Diluted P/E:: -25.4545
RSI(14) 1m:: 100.0
VWAP:: 2.8
RVol:: 0.8046

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.81 -0.05 (-1.75%)	Oct 15 13:13
1m	Price increase 1m	2.95 +0.06 (+2.07%)	Oct 15 12:57
1m	Price increase 1m	2.96 +0.04 (+1.2%)	Oct 15 12:19
1m	Price decrease 1m	2.86 -0.07 (-2.39%)	Oct 15 12:10
1m	Price decrease 1m	2.86 -0.11 (-3.7%)	Oct 15 11:56